Summary
Both Venn-Watson founders discuss how their Navy dolphin research led to the discovery of C15:0 as a longevity biomarker. They share the full story from dolphin health monitoring to identifying pentadecanoic acid as a stronger predictor of healthy aging than omega-3s, and how this translated into creating the Fatty15 supplement for human use.
Key Points
- The discovery came from monitoring the health of Navy dolphins over decades
- C15:0 outperformed omega-3s as a predictor of healthy aging in dolphins
- The transition from dolphin research to human supplement required extensive validation
- Both founders bring complementary expertise in veterinary and human medicine
- Fatty15 was created to deliver pure C15:0 after dietary sources proved insufficient
Key Moments
From Navy dolphins to human longevity supplement
Both Venn-Watson founders describe how monitoring Navy dolphin health for decades led to identifying C15:0 as a key longevity biomarker.
"membrane health, actually, the health of your cells, the health of your membranes of cells. It's about how you can live longer. It's an incredible story about dolphins. So if I haven't got you interested now from between medical emergencies and dolphin stories, I don't know what will get you interested. This is an episode that certainly didn't finish the way we planned, but very, very valuable information. And this is"
